Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MGNX - MacroGenics: Trying To Build A Better Everything

MGNX - MacroGenics: Trying To Build A Better Everything

MacroGenics Inc.

2024-02-15 10:18:57 ET

Summary

  • MacroGenics, Inc. has a pipeline of promising drugs including Vobramitamab Duocarmazine, Lorigerlimab, Tebotelimab, MGD024, and IMGC936.
  • The company has a strong financial position as of their latest report.
  • MacroGenics faces both strengths and risks in their drug development and commercialization efforts.

Top-Line Summary

For further details see:

MacroGenics: Trying To Build A Better Everything
Stock Information
Company Name: MacroGenics Inc.
Stock Symbol: MGNX
Market: NASDAQ
Website: macrogenics.com
Menu
MGNX MGNX Quote MGNX Short MGNX News MGNX Articles MGNX Message Board
Get MGNX Alerts

News, Short Squeeze, Breakout and More Instantly...